Cointime

Novadip Biosciences

company

About

Novadip is transforming the lives of patients using its unique “3M3” tissue regeneration technology platform.

  • 11 - 50

Highlights

Total Funding Amount
€71M
Funding Rounds
3
Investors
3

Details

Last Funding Type
Series B
Last Funding Money Raised
€24M
Industries
Biotechnology,Health Care,Medical,Therapeutics
Founded date
Jan 1, 2013
Number Of Employee
11 - 50
Operating Status
Active

Novadip Biosciences, an advanced biopharmaceutical company focused on new generation of therapies from adipose stem cells adapted to hard and soft tissues reconstruction.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
3
€71M
Novadip Biosciences has raised a total of €71M in funding over 2 rounds. Their latest funding was raised on Nov 3, 2022 from a Series B round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Nov 3, 2022 Series B €24M 1 — — Detail
Oct 28, 2021 Series B €19M 2 the SRIW Life Sciences — Detail
Sep 10, 2015 Series A €28M 1 — — Detail

Investors

Number of Lead Investors
Number of Investors
1
3
Novadip Biosciences is funded by 3 investors. the SRIW Life Sciences and Invest BW are the most recent investors.
Investor Name Lead Investor Funding Round
the SRIW Life Sciences — Series B
Invest BW — Series B
Nivelinvest — Series A
Cointime
เนื้อหา
บริษัท